ezetimibe has been researched along with tak-875 in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (tak-875) | Trials (tak-875) | Recent Studies (post-2010) (tak-875) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 121 | 15 | 116 |
| Protein | Taxonomy | ezetimibe (IC50) | tak-875 (IC50) |
|---|---|---|---|
| Sodium/bile acid cotransporter | Homo sapiens (human) | 2 | |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | 2.41 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 2.28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, Y; Fu, L; Zhang, L | 1 |
1 review(s) available for ezetimibe and tak-875
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2022 |